UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025814
Receipt number R000029687
Scientific Title Development of MMG/EMG Transducer for Evaluation of Skeletal Muscle Contraction
Date of disclosure of the study information 2017/04/01
Last modified on 2018/12/20 17:53:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of MMG/EMG Transducer for Evaluation of Skeletal Muscle Contraction

Acronym

Development of MMG/EMG Transducer

Scientific Title

Development of MMG/EMG Transducer for Evaluation of Skeletal Muscle Contraction

Scientific Title:Acronym

Development of MMG/EMG Transducer

Region

Japan


Condition

Condition

Healthy subject

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Validation of developed MMG/EMG Transducer for Evaluation of Skeletal Muscle Contraction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Validation of MMG and EMG Signal of developed Transducer

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

The subject makes (1)Isometric Contarction, (2)Isotonic Contraction, (3)Pedaling Wheel Chair Exercise by using the developed transducer attached on the muscle surface (totally for an hour).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1)Subject without any problem of the orthopedic desease
2) Subject whose age is elder than 20 years old when he agreed with the IC
3) Subject who submitted the document agreement after he received the enough explanation for participation to this study

Key exclusion criteria

1)Subject with the problem of the exercise function
2)Subject who occurs a rash to the conductive cream
3)Sbject who feels unpleasantly by wearing the transducer
4)Subject whom the investigators judged as an inappropriate subject

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisao Oka

Organization

Okayama University

Division name

Graduate School of Health Sciences

Zip code


Address

2-5-1, Kita-ku, Shikata-cho, Okayama-shi

TEL

086-235-6884

Email

hoka@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hisao Oka

Organization

Okayama University

Division name

Graduate School of Health Sciences

Zip code


Address

2-5-1, Kita-ku, Shikata-cho, Okayama-shi

TEL

086-235-6884

Homepage URL


Email

hoka@md.okayama-u.ac.jp


Sponsor or person

Institute

Okayama University

Institute

Department

Personal name



Funding Source

Organization

Okayama University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The results of MMG and EMG data, measured by the developed MMG / EMG hybrid transducer, reflected the muscle contraction strength during dynamic exercises. Then this transducer is effective in simultaneous measurement of MMG / EMG signals.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2018 Year 11 Month 18 Day

Date of closure to data entry

2018 Year 11 Month 18 Day

Date trial data considered complete

2018 Year 11 Month 18 Day

Date analysis concluded

2018 Year 11 Month 18 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 23 Day

Last modified on

2018 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029687


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name